Brief: Novo Nordisk says its proposed Metsera transaction is consistent with US antitrust law
05/11/2025 20:22
Nov 5 (Reuters) - Novo nordisk, in a statement, says its metsera deal structure is consistent with u.s. Antitrust law Novo nordisk says it is in a constructive dialogue with the us federal trade commission regarding that agency's concerns about the proposed merger
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up